Search

everythinglearnresearchcommunity

for

Search:↓

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

The new compound may be a safer alternative to finasteride for prostate protection.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Niosomes improve aminexil's effectiveness in preventing hair loss without needing propylene glycol.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

A new treatment using dissolvable microneedles with nickel-copper and minoxidil improves hair growth and health in androgenetic alopecia.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

5-Aminosalicylic acid enemas may cause immediate hair root damage and hair loss.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Blocking α-toxin helps heal Staphylococcus aureus-infected wounds faster in both normal and diabetic mice, with different effects on their immune responses.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Using human recombinant hyaluronidase in donor strip harvesting may improve the procedure.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

DMG-Na may help reduce hair loss and improve hair growth, but more research is needed.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Injecting Platelet-Rich Plasma reduces leakage risk in colorectal surgery.